A medical staff member holds a vial of the Pfizer-BioNTech COVID-19 vaccine on Jan 7, 2021. SEOUL: Drugmaker Pfizer has filed an application seeking approval of its COVID-19 vaccines to be used in South Korea as the country gears up to begin inoculations next month, authorities said on Monday .
The Ministry of Food and Drug Safety said it aims to reach a decision within 40 days after cutting its previous deliberation period of up to 180 days to fast-track the approval and speed up the vaccination process."Pfizer submitted the request today for its vaccines produced in Belgium," the ministry said in a statement.
"We will thoroughly review their safety and effectiveness in cooperation with professional examiners and outside experts so that our people can access safe and effective COVID-19 vaccines."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
South Korea to begin using Pfizer COVID-19 vaccines on Feb 27, PM saysSouth Korea will begin administering the first of 117,000 doses of Pfizer's coronavirus vaccine on Feb. 27, a day after the country begins its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Risk from COVID-19 variants remains after first Pfizer COVID-19 vaccine, UK study findsLONDON :A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, ... 所以那些還沒有完成接種第二針疫苗的國家是不能對印度，巴基斯坦，尼泊爾，斯里蘭卡開放的。 3rd and 4th doses coming your way. Then 5th and 6th......... WHILE VIRYS MUTATES
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotSEOUL: One dose of COVID-19 vaccines from AstraZeneca and Pfizer was 86.6 per cent effective in preventing infections among people aged 60 and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotOne dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older, real world data released by South Korea showed on Wednesday. Data by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine, jointly developed by BioNTech, was 89.7% effective in preventing infection at least two weeks after a first dose was given, while the AstraZeneca shot was 86.0% effective. Its analysis is based on more than 3.5 million people in South Korea aged 60 and older for two months from Feb. 26 and included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot.
Source: YahooSG - 🏆 3. / 71 Read more »
Pfizer says South African COVID-19 variant could significantly reduce vaccine protectionA laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »